Clin2
NCT06393868Possibly a fitRecruiting

Preventing stomach bleeding with omeprazole during blood thinner therapy

Venous ThromboembolismGastro Intestinal BleedingBlood Clot

Treatments studied

Part of Digestive system, Heart & circulation clinical trials.

This trial tests whether omeprazole (a stomach acid reducer) can help prevent stomach bleeding in older adults who are taking blood thinners for a newly diagnosed blood clot. It may be a good fit if you are 65 or older and starting blood thinners for a clot.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
360 people
Ages
65 years and older
Study type
Interventional

Who can take part

  • You are 65 years old or older.
  • You have been recently diagnosed with a blood clot (like deep vein thrombosis or pulmonary embolism).
  • You plan to take blood thinners (anticoagulants) for at least 3 months.
  • You are not already taking a daily proton pump inhibitor (like omeprazole).
  • You have never had bleeding from your stomach or upper intestines.
  • You are not taking two different antiplatelet drugs (like aspirin plus clopidogrel).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07125651Not yet recruiting
Gastrointestinal bleeding in heart disease patients on blood thinners

This trial is looking at patients with ischemic heart disease who are taking one or two antiplatelet drugs (like aspirin or clopidogrel) and have had gastrointestinal bleeding. The goal is to study this problem and find better ways to manage it.

NCT04394663Recruiting
High-dose omeprazole by mouth for serious ulcer bleeding

This trial tests whether taking a high dose of omeprazole by mouth can help control bleeding from a peptic ulcer that looks high-risk on endoscopy. It may be aimed at lowering the chance of bleeding again after your procedure.

Pathum Wan, Bangkok
NCT04416581Recruiting· Phase 4
Compare two stomach-protecting medicines to prevent bleeding

This trial compares a potassium-competitive acid blocker to a proton pump inhibitor to help prevent stomach or intestinal bleeding in people at high risk who take blood-thinning medicines. It may help reduce dangerous GI bleeding while you stay on heart/stroke medicines.

Anyang
NCT05582174Recruiting· Phase 4
IV medicine versus pills to stop bleeding stomach ulcers

This trial compares an IV “acid-suppressing” medicine (PPI infusion) with acid pills (oral PPIs) after doctors treat a bleeding peptic ulcer endoscopically. It may help prevent re-bleeding by keeping stomach acid low while the ulcer heals.

Guangzhou, Guangdong
NCT07776730Not yet recruiting
Comparing two acid reducers for stomach bleeding

This trial tests two medicines that lower stomach acid to help stop bleeding from the stomach or intestines. It aims to find which one works better for people with this type of bleeding.

Shenyang, Liaoning
NCT06861478Recruiting· Phase 2
PPIs for bleeding varices in liver disease

This trial tests whether proton pump inhibitors (PPIs) can help people with cirrhosis who are hospitalized for variceal bleeding. It looks at whether PPIs reduce complications during the hospital stay.

Monterrey, Nuevo León

Hear when a new Venous Thromboembolism trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.